Publications by authors named "A Guntani"
Background: The treatment outcomes of vein and bovine pericardial patches in thromboendarterectomy (TEA) for common femoral artery (CFA) lesions in patients with peripheral arterial disease (PAD) remain unclear. The purpose of this study was to evaluate the efficacy and safety of the bovine pericardial patch by comparing it with vein patch angioplasty.
Methods: This was a multicenter retrospective study.
In recent years, endovascular therapy (EVT) has come to play an important role in the revascularization of the femoropopliteal artery region; however, the number of cases that cannot be treated with EVT is increasing, and the importance of bypass surgery has been reaffirmed. We will provide an overview of the revascularization of the femoropopliteal artery region in accordance with the JCS/JSVS 2022 Guideline on the Management of Peripheral Arterial Disease. (This is a translation of Jpn J Vasc Surg 2024; 33: 57-59).
View Article and Find Full Text PDFBackground: This study aimed to analyze the clinical outcomes after revascularization for chronic limb-threatening ischemia (CLTI) in patients aged ≥ 80 years and < 80 years.
Methods: We retrospectively analyzed multicenter data of 789 patients who underwent infrainguinal revascularization for CLTI between 2015 and 2021. The end points were 2-year overall survival (OS), amputation-free survival (AFS), limb salvage (LS), and postoperative complications.
Article Synopsis
- - This study compared the effects of two treatment methods—bypass surgery and endovascular therapy (EVT)—on wound healing in patients with chronic limb-threatening ischemia (CLTI) who have varying conditions of the foot arteries (IM P0 and IM P1).
- - Results showed that bypass surgery led to significantly better wound healing and limb salvage rates in patients with severely diseased pedal arches (IM P1), while both methods had similar outcomes in patients with intact pedal arches (IM P0).
- - The findings suggest that bypass surgery is a more effective option for patients with tissue loss and IM P1 disease, but may not offer additional benefits over EVT for those with healthier foot arteries (IM P0).
Background: Despite the widespread use of PROPATEN, a bioactive heparin-bonded expanded polytetrafluoroethylene graft, in bypass surgery, there are only a few reports of long-term results. We evaluated the long-term results of PROPATENuse for above-knee femoropopliteal bypass (AKFPB).
Methods And Results: After PROPATEN-based AKFPB, patients were prospectively registered at 20 Japanese institutions between July 2014 and October 2017 to evaluate long-term results.